rs2072338
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_001116.4(ADCY9):c.1884+442T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0886 in 152,190 control chromosomes in the GnomAD database, including 840 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.089 ( 840 hom., cov: 32)
Consequence
ADCY9
NM_001116.4 intron
NM_001116.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.74
Publications
3 publications found
Genes affected
ADCY9 (HGNC:240): (adenylate cyclase 9) Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. It is regulated by a family of G protein-coupled receptors, protein kinases, and calcium. The type 9 adenylyl cyclase is a widely distributed adenylyl cyclase, and it is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, calcium, and somatostatin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.284 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADCY9 | NM_001116.4 | c.1884+442T>C | intron_variant | Intron 3 of 10 | ENST00000294016.8 | NP_001107.2 | ||
| ADCY9 | XM_005255079.4 | c.1884+442T>C | intron_variant | Intron 3 of 10 | XP_005255136.1 | |||
| ADCY9 | XM_011522353.3 | c.1884+442T>C | intron_variant | Intron 3 of 10 | XP_011520655.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0885 AC: 13458AN: 152072Hom.: 840 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13458
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0886 AC: 13486AN: 152190Hom.: 840 Cov.: 32 AF XY: 0.0919 AC XY: 6840AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
13486
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
6840
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
4634
AN:
41518
American (AMR)
AF:
AC:
1577
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
119
AN:
3472
East Asian (EAS)
AF:
AC:
1529
AN:
5166
South Asian (SAS)
AF:
AC:
1180
AN:
4820
European-Finnish (FIN)
AF:
AC:
538
AN:
10610
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3639
AN:
68010
Other (OTH)
AF:
AC:
201
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
594
1188
1783
2377
2971
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1094
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.